COVID‐19 vaccine response in people with multiple sclerosis
EC Tallantyre, N Vickaryous, V Anderson… - Annals of …, 2022 - Wiley Online Library
Objective The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …
COVID-19 vaccine response in people with multiple sclerosis
EC Tallantyre, N Vickaryous, V Anderson, AN Asardag… - medRxiv, 2021 - medrxiv.org
Objective To investigate the effect of disease modifying therapies on serological response to
SARS-CoV2 vaccines in people with multiple sclerosis Methods 473 people with multiple …
SARS-CoV2 vaccines in people with multiple sclerosis Methods 473 people with multiple …
[HTML][HTML] COVID-19 vaccine response in people with multiple sclerosis
EC Tallantyre, N Vickaryous, V Anderson, AN Asardag… - 2021 - europepmc.org
Objective To investigate the effect of disease modifying therapies on serological response to
SARS-CoV2 vaccines in people with multiple sclerosis Methods 473 people with multiple …
SARS-CoV2 vaccines in people with multiple sclerosis Methods 473 people with multiple …
[HTML][HTML] COVID‐19 Vaccine Response in People with Multiple Sclerosis
EC Tallantyre, N Vickaryous, V Anderson… - Annals of …, 2022 - ncbi.nlm.nih.gov
Objective The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …
[PDF][PDF] COVID-19 Vaccine Response in People with Multiple Sclerosis
EC Tallantyre, N Vickaryous, V Anderson, AN Asardag… - 2021 - scienceopen.com
Objective: The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
[PDF][PDF] COVID-19 Vaccine Response in People with Multiple Sclerosis
EC Tallantyre, N Vickaryous, V Anderson… - ANN …, 2022 - merckneurology.com
Objective: The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
[PDF][PDF] COVID-19 Vaccine Response in People with Multiple Sclerosis
EC Tallantyre, N Vickaryous, V Anderson… - 2021 - nottingham-repository.worktribe.com
Objective: The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
COVID‐19 Vaccine Response in People with Multiple Sclerosis.
EC Tallantyre, N Vickaryous, V Anderson… - Annals of …, 2022 - search.ebscohost.com
Objective: The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …
COVID-19 Vaccine Response in People with Multiple Sclerosis
EC Tallantyre, N Vickaryous… - Annals of …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS …
COVID-19 vaccine response in people with multiple sclerosis
E Tallantyre, N Vickaryous, V Anderson… - Annals of …, 2022 - orca.cardiff.ac.uk
Objective To investigate the effect of disease modifying therapies on immune response to
SARS-CoV2 vaccines in people with multiple sclerosis. Methods 473 people with multiple …
SARS-CoV2 vaccines in people with multiple sclerosis. Methods 473 people with multiple …